Quantcast

World Allergy Organization’s Official Journal to Become Open Access

December 22, 2012

Expanded global reach will help build knowledge base on asthma and allergic diseases which are increasing in prevalence and complexity worldwide

Milwaukee, Wisc. (PRWEB) December 21, 2012

The World Allergy Organization (WAO) and BioMed Central, the open access publisher, are pleased to announce the World Allergy Organization Journal (WAO Journal), the official journal of the World Allergy Organization (WAO), is moving to BioMed Central’s open access publishing platform to join the publisher´s growing open access allergy portfolio.

The prevalence of allergy and its impact on society continues to rise; therefore access to allergy research is paramount in order to achieve sustainable results towards future prevention, diagnosis and treatment. The growth of interest into allergic diseases is reflected in BioMed Central´s collection of allergy journals and the transition by the WAO to open access.

The World Allergy Organization is an international umbrella organization for the allergy community, whose members consist of 89 regional and national asthma, allergology and clinical immunology societies from around the world.

WAO Journal´s Editor-in-Chief, Dr Lanny Rosenwasser, stated: “The journal has been fully online from the start, so this move to open access is a natural shift, allowing WAO members and other WAO Journal authors to disseminate their research in the burgeoning field of allergy more efficiently.”

The journal is an important vehicle for the World Allergy Organization to be able to ensure that research will reach not only WAO members, but the widest possible global audience. This move is another step toward achieving the aims and vision of the WAO journal: to provide a global forum for the exchange of research and information on allergy, asthma, and clinical immunology.

Dr Ruby Pawankar, President of the World Allergy Organization, said: “As an organization with global reach, it is important for our official journal to mirror the organization´s commitments to improving the knowledge-share needed for immediate care and prevention of asthma and allergic disease, which are becoming more complex and more prevalent worldwide, especially in children, and increasing in the burden on patients as well as societies.”

Beginning in January 2013, WAO Journal readers will have free, instant online access to all published articles not only on BioMed Central’s website, but also on PubMed Central as well as other open access repositories, free from the constraints of print publication cycles.

# # #

Media Contacts

Sofia Dorsano

Director, Publications, Education & Communications

World Allergy Organization

Tel: + 1 414 276 1791

Email: sdorsano (at) worldallergy (dot) org

Rebecca Fairbairn

Public Relations Manager, BioMed Central

Tel: +44 (0) 20 3192 2433

Mob: +44 (0) 7825 257423

Email: rebecca.fairbairn (at) biomedcentral (dot) com

Notes to Editors

1. World Allergy Organization Journal (http://new.waojournal.org/) publishes original research, clinical reviews, position papers, and epidemiological studies that contribute to current knowledge in patient care with authors, reviewers and readers representing all geographic regions, providing a truly global perspective on allergy, asthma and clinical immunology. WAO Journal is accepting submissions; please use the online submission system to submit your manuscript. For enquiries about the journal, please contact: waoj (at) worldallergy (dot) org and journals (at) biomedcentral (dot) com.

2. BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector. @BioMedCentral

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/12/prweb10257964.htm


Source: prweb



comments powered by Disqus